Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

O. Bozkurt · SciRah

Researcher profile · Semantic Scholar

O. Bozkurt

Share profile

O. Bozkurt — researcher profile on SciRah

h-index: 15
Works: 96
Citations: 571

Most-cited papers

Albumin-globulin ratio for prediction of long-term mortality in lung adenocarcinoma patients.
A. Duran, M. Inanc, H. Karaca, I. Dogan +6 more
2014Asian Pacific Journal of Cancer Prevention61 citations Open access
Semantic Scholar
Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer
M. Inanc, M. Ozkan, H. Karaca, V. Berk +6 more
2013Medical Oncology60 citations
Semantic Scholar
Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients.
O. Bozkurt, H. Karaca, V. Berk, M. Inanc +4 more
2015Journal of B.U.ON. : official journal of the Balkan Union of Oncology37 citations
Semantic Scholar
Factors affecting prognosis in metastatic colorectal cancer patients.
Baki Eker, E. Ozaslan, H. Karaca, V. Berk +4 more
2015Asian Pacific Journal of Cancer Prevention31 citations Open access
Semantic Scholar
Thyroid volume in patients with glucose metabolism disorders.
A. Duran, C. Anil, A. Gursoy, A. Nar +3 more
2014Arquivos brasileiros de endocrinologia e metabologia27 citations Open access
Semantic Scholar
Clinicopathological characteristics and prognosis of patients according to recurrence time after curative resection for colorectal cancer.
O. Bozkurt, M. Inanc, E. Turkmen, H. Karaca +8 more
2014Asian Pacific Journal of Cancer Prevention25 citations Open access
Semantic Scholar
Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?
O. Bozkurt, H. Karaca, I. Hacıbekiroglu, M. A. Kaplan +8 more
2015Journal of chemotherapy22 citations
Semantic Scholar
Positive effects of oral β-glucan on mucositis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy.
H. Karaca, O. Bozkurt, E. Ozaslan, S. Baldane +6 more
2014Asian Pacific Journal of Cancer Prevention21 citations Open access
Semantic Scholar
Hepatic steatosis is associated with higher incidence of liver metastasis in patients with metastatic breast cancer; an observational clinical study.
Ayse Ocak Duran, Afra Yıldırım, M. Inanc, H. Karaca +5 more
2015Journal of B.U.ON. : official journal of the Balkan Union of Oncology20 citations
Semantic Scholar
Haematologic parameters in metastatic colorectal cancer patients treated with capecitabine combination therapy.
M. Inanc, A. Duran, H. Karaca, V. Berk +3 more
2014Asian Pacific Journal of Cancer Prevention20 citations Open access
Semantic Scholar
A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma
Mete Gundog, Hatice Basaran, O. Bozkurt, C. Eroglu
2019Brazilian Journal of Otorhinolaryngology18 citations Open access
Semantic Scholar
Hormone receptor status and survival of medullary breast cancer patients
A. Aksoy, H. Odabaş, S. Kaya, O. Bozkurt +10 more
2017Saudi Medical Journal18 citations Open access
Semantic Scholar
Impact of neutrophil-lymphocyte and platelet-lymphocyte ratio on antiEGFR and bevacizumab efficacy in metastatic colorectal cancer.
E. Doğan, O. Bozkurt, T. Şakalar, Sumeyra Derin +2 more
2019Journal of B.U.ON. : official journal of the Balkan Union of Oncology17 citations
Semantic Scholar
Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO)
O. Unal, I. Oztop, N. Yasar, Z. Urakçı +12 more
2015Thoracic Cancer16 citations Open access
Semantic Scholar
Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab.
V. Berk, K. Deniz, O. Bozkurt, E. Ozaslan +4 more
2015Asian Pacific Journal of Cancer Prevention15 citations Open access
Semantic Scholar
Primary Pleomorphic Rhabdomyosarcoma of Thyroid Gland in an Adult Patient: A Case Report.
E. Ozaslan, V. Berk, S. Baldane, Baki Eker +6 more
2016Eurasian Journal of Medicine12 citations Open access
Semantic Scholar
The relationship between thyroid volume and malignant thyroid disease
A. Duran, C. Anil, A. Gursoy, A. Nar +4 more
2013Medical Oncology12 citations
Semantic Scholar
Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology
O. Ercelep, T. Topcu, I. Bayoğlu, A. Ekinci +14 more
2016Tumor Biology11 citations
Semantic Scholar
The prognostic value of the change in neutrophil-to-lymphocyte ratio during first-line palliative chemotherapy in patients with metastatic gastric cancer: A retrospective study.
O. Bozkurt, S. Fırat, E. Doğan, R. Coşar +2 more
2019Journal of B.U.ON. : official journal of the Balkan Union of Oncology10 citations
Semantic Scholar
Analyses of multiple factors for determination of "selected patients" who should receive rechallenge treatment in metastatic colorectal cancer: a retrospective study from Turkey.
E. Ozaslan, A. Duran, O. Bozkurt, M. Inanc +5 more
2015Asian Pacific Journal of Cancer Prevention10 citations Open access
Semantic Scholar
Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients?
O. Bozkurt, I. Hacıbekiroglu, M. Kaplan, Y. Duzkopru +8 more
2015Clinical Genitourinary Cancer9 citations
Semantic Scholar
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer
Yusuf Ilhan, A. Tatlı, Fatih Teker, A. Onder +20 more
2022International Journal of Gynecological Cancer8 citations Open access
Semantic Scholar
Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less
Ersin Özaslan, H. Karaca, S. Koca, A. Sevınc +15 more
2017Anti-Cancer Drugs7 citations Open access
Semantic Scholar
Clinicopathological characteristics and prognosis of patients according to recurrence time after radical nephrectomy for localized renal cell carcinoma: a multicenter study of Anatolian Society of Medical Oncology (ASMO).
O. Bozkurt, M. Inanc, I. Hacıbekiroglu, O. Eşbah +15 more
2014Anticancer Research7 citations
Semantic Scholar
Lack of prognostic value of mean corpuscular volume with capecitabine therapy in metastatic breast cancer.
O. Bozkurt, V. Berk, M. A. Kaplan, B. Cetin +5 more
2014Asian Pacific Journal of Cancer Prevention7 citations Open access
Semantic Scholar
Efficacy and safety of raltitrexed combinations with uracil- tegafur or mitomycin C as salvage treatment in advanced colorectal cancer patients: a multicenter study of Anatolian Society of Medical Oncology (ASMO).
O. Bozkurt, H. Karaca, Aydın Çiltaş, M. A. Kaplan +8 more
2014Asian Pacific Journal of Cancer Prevention6 citations Open access
Semantic Scholar
Moxifloxacin-associated neutropenia
V. Berk, Hayati Demiraslan, E. Berk, H. Karaca +3 more
2013Scandinavian Journal of Infectious Diseases6 citations
Semantic Scholar
The prognostic importance of the global immune-nutrition-information index (GINI) in patients with Ras wild type metastatic colorectal cancer
O. Bozkurt, Rıdvan Gönül, B. Kaya, G. Zararsiz +2 more
2025Scientific Reports5 citations Open access
Semantic Scholar
Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non-Small-Cell Lung Cancer.
A. Duran, M. Inanc, O. Bozkurt, E. Ozaslan +1 more
2023Clinical Lung Cancer5 citations
Semantic Scholar
Is SUVmax of 18F-FDG PET/CT Predictive Factor for Malignancy in Gastrointestinal Tract?
E. Ozaslan, Melih Kızıltepe, Ummuhan Addulrezzak, M. Kula +9 more
2021Nigerian Journal of Clinical Practice5 citations Open access
Semantic Scholar
The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer
M. Inanc, H. A. Sırakaya, H. Karaman, O. Bozkurt
2020Journal of Oncology Pharmacy Practice5 citations
Semantic Scholar
Prognostic impact of elevated C-reactive protein and procalcitonin in patients with extensive-stage small cell lung cancer
Irfan Bugday, M. Inanc, Metin Özkan, O. Bozkurt +6 more
2024Anti-Cancer Drugs4 citations
Semantic Scholar
Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology).
A. Süner, D. Aydın, M. B. Hacıoğlu, G. Dogu +18 more
2016European Review for Medical and Pharmacological Sciences4 citations
Semantic Scholar
Impact of renin–angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non–small cell lung cancer
Emel Mutlu Ozkan, İ. Karadağ, Elif Şahin, Ayşe Nuransoy Cengiz +32 more
2026Expert Review of Anticancer Therapy3 citations
Semantic Scholar
Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer.
A. Topçu, M. Atcı, Şaban Seçmeler, M. Beşiroğlu +8 more
2021Future Oncology3 citations
Semantic Scholar
The Impact of Lymphovascular Invasion on Recurrence-Free Survival in Patients with High-Risk Stage II Colorectal Cancer Treated with Adjuvant Therapy
O. Bozkurt, S. Fırat, E. Doğan, M. Inanc +3 more
20193 citations
Semantic Scholar
Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder
G. Erdem, M. Doğan, A. Sakin, Z. Oruç +13 more
2018Oncology Research and Treatment3 citations Open access
Semantic Scholar
Role of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Predictors Before Treatment for Metastatic Bladder Cancer Patients Receiving First-Line Chemotherapy
O. Bozkurt, E. Doğan, S. Fırat, R. Coşar +3 more
20192 citations
Semantic Scholar
Real-world practices in RAS wild-type metastatic colorectal cancer patients treated with targeted agents in the first-line a nationwide onco-colon Turkey registry
Dilek Tatlıdede, Ç. Arslan, M. Yıldırım, A. Işıkdoğan +25 more
2026Anadolu Kliniği Tıp Bilimleri Dergisi1 citations Open access
Semantic Scholar
Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study
Mustafa Ersoy, Umut Kefeli, D. Çabuk, E. Bayram +23 more
2026Frontiers in Immunology1 citations
Semantic Scholar
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients
Muhammet Cengiz, O. Bozkurt, A. Cengiz, D. Guven +31 more
2026Scientific Reports1 citations Open access
Semantic Scholar
Prognostic role of prognostic nutritional index change in patients with extensive stage small cell lung cancer treated with platinum-based chemotherapy
Irfan Bugday, M. Inanc, Metin Özkan, O. Bozkurt +6 more
2025BMC Cancer1 citations Open access
Semantic Scholar
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC
M. Yıldırım, N. Karadurmuş, I. Ökten, H. Türk +25 more
2024Journal of Oncology Pharmacy Practice1 citations Open access
Semantic Scholar
Risk factors for 30-day mortality in patients with cancer and COVID-19 in Turkey: A single Center retrospective study
E. Mutlu, S. Fırat, Mevl Nan, O. Bozkurt +2 more
2022Annals of Medical Research1 citations Open access
Semantic Scholar
P-92 Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study
M. Artaç, E. Çubukçu, O. Bozkurt, A. Bilici +18 more
2022Annals of Oncology1 citations Open access
Semantic Scholar
P-219 Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, RAS wild-type, metastatic colon cancer: A multicenter Onco-Colon Turkey study
Ç. Arslan, U. Kefeli, E. Yıldırım, A. Işıkdoğan +17 more
2021Annals of Oncology1 citations Open access
Semantic Scholar
Role of Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Predictors for Survival in Metastatic Bladder Cancer Patients Receiving Fist-Line Chemotherapy
O. Bozkurt
2019Erciyes Medical Journal1 citations Open access
Semantic Scholar
The impact of lymphovascular invasion on recurrence-free survival in high-risk stage II colorectal cancer patients treated with adjuvant therapy.
O. Bozkurt
2019Erciyes Medical Journal1 citations Open access
Semantic Scholar
Pretreatment Inflammatory Indexes are Associated with Response to First-Line Platinum- Based Chemotherapy and Prognosis of Small Cell Lung Cancer Patients
M. Inanc, O. Bozkurt, A. Duran, M. Ozkan +1 more
20191 citations
Semantic Scholar
Clinical outcomes of patients with pure small cell carcinoma of the urinary bladder
G. Erdem, M. Doğan, Aydin Aytekin, S. Şahin +8 more
2019Irish Journal of Medical Science1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Inanc×31
Invite
M. Inanc — researcher profile on SciRah
M. Ozkan×23
Invite
M. Ozkan — researcher profile on SciRah
A. Duran×18
Invite
A. Duran — researcher profile on SciRah
H. Karaca×18
Invite
H. Karaca — researcher profile on SciRah

×16

Invite

V. Berk — researcher profile on SciRah

Invite

E. Ozaslan — researcher profile on SciRah

Invite

Mahmut Ucar — researcher profile on SciRah

Invite

M. Uysal — researcher profile on SciRah

Invite

M. Ozcelik — researcher profile on SciRah

Invite

S. Fırat — researcher profile on SciRah

Ç. Geredeli×6

Invite

Ç. Geredeli — researcher profile on SciRah

Metin Özkan×6

Invite

Metin Özkan — researcher profile on SciRah